STAAR Low-Grade Serous Ovarian Cancer’s Post

Together with STAAR Ovarian Cancer we are establishing the inaugural 𝗟𝗼𝘄-𝗚𝗿𝗮𝗱𝗲 𝗦𝗲𝗿𝗼𝘂𝘀 𝗢𝘃𝗮𝗿𝗶𝗮𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗗𝗮𝘆 (𝗟𝗚𝗦𝗢𝗖 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗗𝗮𝘆) 𝗼𝗻 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟵. LGSOC is a rare ovarian cancer that often affects younger women and there are no FDA-approved treatments. Join us and the entire LGSOC community by participating in our campaign on September 9th using these social media materials: https://lnkd.in/gxPzyit4 Read our press release to learn more: https://lnkd.in/ewtDnRb6 #LGSOCAwarenessDay #LGSOC #OvarianCancer #VerastemOnc #OvarianCancerAwarenessMonth

In Ovarian Cancer Awareness month (September), Monday, Sep 9th marks the inaugural LGSOC Awareness Day. Learn more about this rare form of ovarian cancer that often impacts younger women (median age ~45) and can be misdiagnosed as IBS. Spread the word on symptoms and screening options! #LGSOC #LGSOCAwarenessDay #OvarianCancer #OvarianCancerAwarenessMonth

🎥 Replay Now Available: Hereditary Ovarian Cancer Roundtable Listen to Dr. Asima Mukhopadhyay, and a panel of other global experts, delve into challenges and solutions for hereditary ovarian cancer care in one of our 4th Virtual Global Partner Meeting sessions. Watch the replay here: https://loom.ly/WtzrMYs #GlobalCancerCare #NoWomanLeftBehind

For this year's World Pancreatic Cancer Day, let’s take a moment to say ‘Hello Pancreas!’ It’s time to learn about this hardworking organ, spot the warning signs of pancreatic cancer early and help save lives. Awareness can make a real difference. Let’s take action together! #clinicalresearchmy #advancingclinicalresearch #askusaboutclinicalresearch #hellopancreas #worldpancreaticcancerday

💔 Pancreatic Cancer: The Urgency of Action The 12-month survival rate for stage 4 pancreatic cancer is just 20%, with the 5-year survival rate only 12.5%. These stark statistics highlight the critical need for better treatment options and more research. Your participation in the 24-Hour Challenge—whether individually or as part of a team—can help us change these numbers. Support our efforts: https://lnkd.in/dYPCVPKT #24HourChallenge #PancreaticCancer #FightCancer #JoinUs #TeamChallenge

Early detection of Pancreatic Cancer is critical and greatly increases survival rates. We are dedicated to the fight against Pancreatic Cancer; this includes funding early detection research. Click the link to learn more. 💜 https://ow.ly/thHh50TZGx0 #KnowMyRisk #EarlyDetection #PancreaticCancer #PancreasCancer #PancreaticCancerResearch #PancreaticCancerAwareness

Unveiling the Process: How Ovarian Cancer is Diagnosed. As we recognize Ovarian Cancer Awareness Month this September, understanding these crucial steps can empower early detection and save lives. #EarlyDetection #OvarianCancerAwareness #GPCA

PRISM, a groundbreaking model developed with 87 key features from #RealWorldData, is set to revolutionize clinical practice. With the support of TriNetX's network, PRISM paves the way for enhanced screening criteria and identifying high-risk individuals byeond pancreatic cancer. Read the full blog post: https://ow.ly/NfGy30sB16G #PancreaticCancer #HealthcareInnovation

💔 Pancreatic Cancer: The Urgency of Action The 12-month survival rate for stage 4 pancreatic cancer is just 20%, with the 5-year survival rate only 12.5%. These stark statistics highlight the critical need for better treatment options and more research. Your participation in the 24-Hour Challenge—whether individually or as part of a team—can help us change these numbers. Support our efforts: https://lnkd.in/gesGhQK8 #24HourChallenge #PancreaticCancer #FightCancer #JoinUs #TeamChallenge

PRISM, a groundbreaking model developed with 87 key features from #RealWorldData, is set to revolutionize clinical practice. With the support of TriNetX's network, PRISM paves the way for enhanced screening criteria and identifying high-risk individuals beyond pancreatic cancer. Read the full blog post: https://ow.ly/gMsY30sCYUI #PancreaticCancer #HealthcareInnovation